Position in SNDX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$8,095,129
+$3,854,075 QoQ
Shares Held
370,317
+104.0% QoQ
Ownership
0.415%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#53
of 242 holders
Holding Since
Mar 2020
15 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in SNDX Over Time
Shares Held
Position Value (USD)
Derivatives in SNDX
reported options exposure · as of Sep 30, 2024CallValue
$288,750
CallShares
15,000
PutValue
$288,750
PutShares
15,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Squarepoint Ops LLC holds $1,234,876,212 across 255 Biotechnology names. SNDX ranks #37 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
198,567 | $123,814,467 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
1,191,732 | $88,760,199 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
233,999 | $70,440,718 | |
| 4 | INSM |
INSMED Inc
|
616,464 | $65,727,391 | |
| 5 | ARGX |
Argenx SE
|
58,400 | $54,181,768 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
422,921 | $46,956,918 | |
| 7 | APGE |
Apogee Therapeutics, Inc.
|
290,713 | $38,586,336 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
154,605 | $37,842,665 |
All Filings in SNDX
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,095,129 | 370,317 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $4,241,054 | 181,552 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $416,292 | 19,814 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $546,459 | 35,519 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $348,911 | 37,257 | Shares | Defined | 2025-08-27 | |
| 2024-09-30 | $288,750 | 15,000 | Put | Defined | 2024-11-14 | |
| 2024-09-30 | $288,750 | 15,000 | Call | Defined | 2024-11-14 | |
| 2023-12-31 | $1,124,476 | 52,035 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $422,822 | 29,120 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $822,193 | 39,283 | Shares | Defined | 2023-08-14 | |
| 2021-06-30 | $559,312 | 32,575 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $595,648 | 26,639 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $2,026,664 | 91,127 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $966,543 | 65,484 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $301,038 | 20,313 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $354,945 | 32,356 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||